Similar articles

• Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndrome.

  Evans DL, Lynch KG, Benton T, Dubé B, Gettes DR, Tustin NB, Lai JP, Metzger D, Douglas SD. Evans DL, et al. Biol Psychiatry. 2008 May 1;63(9):899-905. doi: 10.1016/j.biopsych.2007.08.012. Epub 2007 Oct 22. Biol Psychiatry. 2008. PMID: 17945197 Free PMC article. Clinical Trial.
• [Evidence for psychopharmacological treatment of depression in children and adolescents?].

  Thomsen PH, Sørensen MJ. Thomsen PH, et al. Ugeskr Laeger. 2007 Apr 2;169(14):1289-94. Ugeskr Laeger. 2007. PMID: 17437688 Review. Danish.
• Rapid worsening of depressive symptoms in a patient with depression after switching from a TCA to an SSRI.

  Sato K, Yoshida K, Higuchi H, Shimizu T. Sato K, et al. J Neuropsychiatry Clin Neurosci. 2002 Summer;14(3):357. doi: 10.1176/jnp.14.3.357. J Neuropsychiatry Clin Neurosci. 2002. PMID: 12154166 No abstract available.
• Mifepristone in psychotic depression?

  Carroll BJ, Rubin RT. Carroll BJ, et al. Biol Psychiatry. 2008 Jan 1;63(1):e1; author reply e3. doi: 10.1016/j.biopsych.2007.03.032. Epub 2007 Oct 24. Biol Psychiatry. 2008. PMID: 17919458 No abstract available.
• First-line pharmacotherapies for depression - what is the best choice?

  Koenig AM, Thase ME. Koenig AM, et al. Pol Arch Med Wewn. 2009 Jul-Aug;119(7-8):478-86. Pol Arch Med Wewn. 2009. PMID: 19776688 Review.